Pfizer Said to Consider Rising AstraZeneca Bid

U.S. drugmaker Pfizer Inc (PFE) is considering raising its bid for Britain’s second-biggest pharmaceutical company AstraZeneca, Reuters reported on Sunday, citing people familiar with the matter. Pfizer and its advisers are still hoping to get AstraZeneca into negotiations before the May 26 deadline, but the gap in pricing the company between the two sides is […] View the full post at: Pfizer Said to Consider Rising AstraZeneca Bid Related posts: Delinquencies Rising Even Among Prime Borrowers Walt Disney to Acquire Marvel Entertainment for $4B Ever Wondered How the Private Equity Industry Works?